{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:34:17Z","timestamp":1792197257751,"version":"4.4.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009447","name":"Leukemia and Lymphoma Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000046","name":"National Research Council Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.stem.2020.04.005","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T10:35:11Z","timestamp":1589452511000},"page":"110-124.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors"],"prefix":"10.1016","volume":"27","author":[{"given":"Katharina","family":"Rothe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Babaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Nakamichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn C.","family":"Chafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akie","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixie L.","family":"Mager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie J.","family":"Eaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoukat","family":"Dedhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2020.04.005_bib64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.stem.2020.04.005_bib1","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1158\/1078-0432.CCR-14-2146","article-title":"Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations","volume":"21","author":"Alvarez-Calderon","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 2","key":"10.1016\/j.stem.2020.04.005_bib2","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1007\/s00277-015-2322-2","article-title":"A review of the European LeukemiaNet recommendations for the management of CML","volume":"94","author":"Baccarani","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.stem.2020.04.005_bib3","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1158\/1535-7163.MCT-08-0314","article-title":"Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance","volume":"7","author":"Bewry","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.stem.2020.04.005_bib4","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.stem.2020.04.005_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jnci\/djt006","article-title":"Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex","volume":"105","author":"Chen","year":"2013","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.stem.2020.04.005_bib6","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease","volume":"118","author":"Chomel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.stem.2020.04.005_bib7","doi-asserted-by":"crossref","first-page":"35293","DOI":"10.18632\/oncotarget.9182","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation","volume":"7","author":"Chomel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.stem.2020.04.005_bib8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.stem.2020.04.005_bib9","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.stem.2020.04.005_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stem.2020.04.005_bib11","first-page":"4409","article-title":"Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival.","volume":"9","author":"Dai","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stem.2020.04.005_bib12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.leukres.2015.09.005","article-title":"Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia","volume":"39","author":"de la Puente","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.stem.2020.04.005_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: Database for Annotation, Visualization, and Integrated Discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.stem.2020.04.005_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2020.04.005_bib15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2020.04.005_bib16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/leu.2014.245","article-title":"Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia","volume":"29","author":"Eiring","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2020.04.005_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.stem.2020.04.005_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3747\/co.v15i2.224","article-title":"An approach to the management of chronic myeloid leukemia in British Columbia","volume":"15","author":"Forrest","year":"2008","journal-title":"Curr. Oncol."},{"issue":"D1","key":"10.1016\/j.stem.2020.04.005_bib19","doi-asserted-by":"crossref","first-page":"D766","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.stem.2020.04.005_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in\u00a0vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.stem.2020.04.005_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/379091a0","article-title":"Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase","volume":"379","author":"Hannigan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.stem.2020.04.005_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc1524","article-title":"Integrin-linked kinase: a cancer therapeutic target unique among its ILK","volume":"5","author":"Hannigan","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.stem.2020.04.005_bib23","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: stemming the tide of persistence","volume":"129","author":"Holyoake","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.stem.2020.04.005_bib24","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.stem.2020.04.005_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrm3772","article-title":"Metabolic requirements for the maintenance of self-renewing stem cells","volume":"15","author":"Ito","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.stem.2020.04.005_bib65","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2019.232793","article-title":"The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remission","author":"Jeanpierre","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.stem.2020.04.005_bib26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2020.04.005_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1535-7163.MCT-07-0042","article-title":"CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells","volume":"7","author":"Jin","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.stem.2020.04.005_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.stem.2020.04.005_bib29","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr2252","volume":"11","author":"Kalra","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.stem.2020.04.005_bib30","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.stem.2020.04.005_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","article-title":"BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance","volume":"108","author":"Koptyra","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.stem.2020.04.005_bib32","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2020.04.005_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3324\/haematol.2017.169946","article-title":"CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting","volume":"103","author":"Landberg","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.stem.2020.04.005_bib34","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.18632\/oncotarget.2353","article-title":"Selective JAK2\/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem\/progenitor cells","volume":"5","author":"Lin","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.stem.2020.04.005_bib66","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2019003636","article-title":"The miR-185\/PAK6 Axis Predicts Therapy Response and Regulates Survival of Drug-Resistant Leukemic Stem Cells in CML","author":"Lin","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.stem.2020.04.005_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-62703-128-8_15","article-title":"Human long-term culture initiating cell assay","volume":"946","author":"Liu","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.stem.2020.04.005_bib36","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/leu.2017.108","article-title":"A novel AHI-1-BCR-ABL-DNM2 complex regulates leukemic properties of primitive CML cells through enhanced cellular endocytosis and ROS-mediated autophagy","volume":"31","author":"Liu","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2020.04.005_bib37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.stem.2020.04.005_bib38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.stem.2020.04.005_bib39","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1242\/jcs.017996","article-title":"Integrin-linked kinase: essential roles in physiology and cancer biology","volume":"121","author":"McDonald","year":"2008","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.stem.2020.04.005_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.exphem.2016.12.012","article-title":"Analysis of parameters that affect human hematopoietic cell outputs in mutant c-kit-immunodeficient mice","volume":"48","author":"Miller","year":"2017","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.stem.2020.04.005_bib41","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2020.04.005_bib42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.exphem.2009.01.002","article-title":"Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells","volume":"37","author":"Muranyi","year":"2009","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.stem.2020.04.005_bib43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fonc.2012.00030","article-title":"Role of STAT3 in transformation and drug resistance in CML","volume":"2","author":"Nair","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.stem.2020.04.005_bib44","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/bcr2592","article-title":"Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development","volume":"12","author":"Oloumi","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.stem.2020.04.005_bib45","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2020.04.005_bib69","unstructured":"R Core Team. (2018). R: A Language and Environment for Statistical Computing. Vienna, Austria. Retrieved from https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.stem.2020.04.005_bib46","doi-asserted-by":"crossref","first-page":"prot5439","DOI":"10.1101\/pdb.prot5439","article-title":"Purification of RNA using TRIzol (TRI reagent).","volume":"2010","author":"Rio","year":"2010","journal-title":"Cold Spring Harbor Protoc."},{"key":"10.1016\/j.stem.2020.04.005_bib47","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1182\/blood-2013-07-516807","article-title":"The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem\/progenitor cells","volume":"123","author":"Rothe","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.stem.2020.04.005_bib48","first-page":"2195","article-title":"Colony forming cell (CFC) assay for human hematopoietic cells","volume":"46","author":"Sarma","year":"2010","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.stem.2020.04.005_bib68","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of Image Analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.stem.2020.04.005_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-319-97746-1_6","article-title":"Preservation of quiescent chronic myelogenous leukemia stem cells by the bone marrow microenvironment","volume":"1100","author":"Shah","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.stem.2020.04.005_bib50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.stem.2020.04.005_bib51","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2020.04.005_bib52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bcp.2010.05.001","article-title":"Targeted therapy of chronic myeloid leukemia","volume":"80","author":"Sullivan","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.stem.2020.04.005_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.onc.1204052","article-title":"Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef\/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-\/- human colon carcinoma cells","volume":"20","author":"Tan","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.stem.2020.04.005_bib54","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1634\/theoncologist.2017-0325","article-title":"A first-in-human phase I study of OPB-111077, a small-molecule STAT3 and oxidative phosphorylation inhibitor, in patients with advanced cancers","volume":"23","author":"Tolcher","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.stem.2020.04.005_bib55","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stem.2020.04.005_bib67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2020.04.005_bib56","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/leu.2011.360","article-title":"Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib","volume":"26","author":"Weisberg","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2020.04.005_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/emboj.2009.376","article-title":"The ILK\/PINCH\/parvin complex: the kinase is dead, long live the pseudokinase!","volume":"29","author":"Wickstr\u00f6m","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.stem.2020.04.005_bib58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200108077","article-title":"Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes","volume":"155","author":"Wu","year":"2001","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.stem.2020.04.005_bib59","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/leu.2010.158","article-title":"AML xenograft efficiency is significantly improved in NOD\/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3","volume":"24","author":"Wunderlich","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2020.04.005_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2020.04.005_bib61","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molcel.2017.06.033","article-title":"Focal adhesion- and IGF1R-dependent survival and migratory pathways mediate tumor resistance to mTORC1\/2 inhibition","volume":"67","author":"Yoon","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.stem.2020.04.005_bib62","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/ncb0807-858","article-title":"Functional atlas of the integrin adhesome","volume":"9","author":"Zaidel-Bar","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.stem.2020.04.005_bib63","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-\u03b2-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590920301442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590920301442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:49:21Z","timestamp":1761832161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590920301442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1934590920301442"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2020.04.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737946788.793583304","asserted-by":"object"}]},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2020.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}